Get the Stockscreener App
0.97
6.57%
0.0598
After Hours:
.96
-0.01
-1.03%
Cytosorbents Corp Stock (CTSO) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
12.90%
9.7863
|
8.6682 | 8.8108 | 9.4208 | 9.4495 |
| Cost Of Revenue |
4.21%
3.2157
|
3.3569 | 3.204 | 3.4023 | 3.9942 |
| Gross Profit |
23.71%
6.5706
|
5.3113 | 5.6069 | 6.0186 | 5.4553 |
Operating Expenses
|
21.90%
11.50
|
14.72 | 12.96 | 12.58 | 13.35 |
| Benefits Costs and Expenses |
16.14
|
- | - | - | - |
| Costs And Expenses |
10.69%
16.14
|
18.08 | 16.16 | 15.98 | 17.34 |
| Depreciation and Amortization |
0.67%
0.3973
|
0.3946 | 0.4072 | 0.402 | 0.2586 |
| Operating Income/Loss |
47.65%
-4.9255
|
-9.4082 | -7.3502 | -6.5592 | -7.8916 |
| Nonoperating Income/Loss |
153.19%
-1.4323
|
2.6928 | -1.8433 | 0.4062 | 0.5657 |
| Income/Loss From Continuing Operations Before Tax |
173.35%
-6.3579
|
8.6682 | -9.1935 | -6.1531 | -7.3259 |
| Income/Loss From Continuing Operations After Tax |
8.96%
-6.3579
|
-5.8349 | -9.1935 | -6.1531 | -7.3259 |
|
Net Income/Loss
|
8.96%
-6.3579
|
-5.8349 | -9.1935 | -6.1531 | -7.3259 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
8,487%
54.26
|
0.6319 | 44.37 | 44.02 | 43.68 |
| Diluted Average Shares |
8,487%
54.26
|
0.6319 | 44.37 | 44.02 | -0.2565 |
| Basic Earnings Per Share |
0.00%
-0.12
|
-0.12 | -0.21 | -0.14 | -0.17 |
| Diluted Earnings Per Share |
0.00%
-0.12
|
-0.12 | -0.21 | -0.14 | -0.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.73%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):